Strategic Global Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Strategic Global Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-129,970	Closed	-$1.6M	–	177
2021 Q1	$1.6M	Sell	129,970 -76,820	-37%	-$987K	0.29%	107
2020 Q4	$2.95M	Sell	206,790 -57,160	-22%	-$770K	0.52%	63
2020 Q3	$3.67M	Buy	263,950 +170,700	+183%	+$2.03M	0.69%	48
2020 Q2	$989K	Sell	93,250 -17,750	-16%	-$181K	0.21%	107
2020 Q1	$895K	Buy	111,000 +56,700	+104%	+$473K	0.23%	95
2019 Q4	$441K	Buy	+54,300	New	+$429K	0.09%	125
2016 Q4	–	Sell	-32,600	Closed	-$334K	–	165
2016 Q3	$334K	Hold	32,600	–	–	0.12%	130
2016 Q2	$334K	Hold	32,600	–	–	0.13%	128
2016 Q1	$295K	Buy	+32,600	New	+$291K	0.13%	126

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Strategic Global Advisors's RDY Position: Q2 2021 in Review

Strategic Global Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q2 2021, closing a stake of 129,970 shares — an estimated $1.6M sold.

Strategic Global Advisors first reported a position in RDY in Q1 2016 and held it in 9 quarters. The position peaked at $3.67M in Q3 2020. 161 funds tracked by Wall St. Rank hold RDY as of Q2 2021.

Strategic Global Advisors reported no remaining Dr. Reddy's Laboratories position as of Q2 2021 after selling out during the quarter.
Strategic Global Advisors sold 129,970 Dr. Reddy's Laboratories shares in Q2 2021, an estimated $1.6M.
Strategic Global Advisors first reported a position in Dr. Reddy's Laboratories in Q1 2016 and held it in 9 quarters.
Strategic Global Advisors's Dr. Reddy's Laboratories position peaked at $3.67M in Q3 2020.
161 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2021.

Based on Strategic Global Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.